Document is current
Any future updates will be listed below
-
Authors
Magrin, Elisa
Semeraro, Michaela
Hebert, Nicolas https://orcid.org/0000-0003-0232-831X
Joseph, Laure
Magnani, Alessandra
Chalumeau, Anne
Gabrion, Aurélie https://orcid.org/0000-0002-1885-2071
Roudaut, Cécile
Marouene, Jouda
Lefrere, Francois
Diana, Jean-Sebastien https://orcid.org/0000-0001-8806-011X
Denis, Adeline
Neven, Bénédicte
Funck-Brentano, Isabelle
Negre, Olivier
Renolleau, Sylvain https://orcid.org/0000-0002-0638-5613
Brousse, Valentine https://orcid.org/0000-0002-4984-754X
Kiger, Laurent
Touzot, Fabien
Poirot, Catherine
Bourget, Philippe
El Nemer, Wassim https://orcid.org/0000-0001-8184-427X
Blanche, Stéphane
Tréluyer, Jean-Marc
Asmal, Mohammed
Walls, Courtney
Beuzard, Yves
Schmidt, Manfred
Hacein-Bey-Abina, Salima
Asnafi, Vahid
Guichard, Isabelle
Poirée, Maryline
Monpoux, Fabrice
Touraine, Philippe
Brouzes, Chantal
de Montalembert, Mariane
Payen, Emmanuel https://orcid.org/0000-0002-1329-2327
Six, Emmanuelle https://orcid.org/0000-0001-7806-0968
Ribeil, Jean-Antoine
Miccio, Annarita https://orcid.org/0000-0002-3409-9665
Bartolucci, Pablo
Leboulch, Philippe https://orcid.org/0000-0002-9196-0255
Cavazzana, Marina https://orcid.org/0000-0002-0264-0891
- License Information
-
More Information
Article History
Received: 8 December 2020
Accepted: 30 November 2021
First Online: 24 January 2022
Competing interests
: P.L. is a scientific founder of Bluebird Bio, with stock options. P.L. is an inventor of awarded patents that claim the βA-T87Q-globin gene, the LentiGlobin BB305 vector and packaging plasmids. O.N., M.A., C.W. and J.A.R. are current or former employees of Bluebird Bio, with stock options. The remaining authors declare no competing interests.
